je.st
news
Tag: drug
Toyota's top female executive arrested on suspicion of drug law violations in Japan resigns
2015-07-01 10:54:39| Automakers - Topix.net
Julie Hamp, the most senior female executive at Toyota who was arrested in Japan last month on suspicion of drug law violations, has resigned from the company, the automaker said Wednesday. Hamp tendered her resignation Tuesday through her attorneys, according to Toyota Motor Corp. It said the company accepted it because of "the concerns and inconvenience that recent events have caused our stakeholders."
MM-398 Receiving The Priority Review Designation By US FDA For New Drug Application And The Acceptance Of Market Authorization Application By EMA In Post-Gemcitabine Metastatic Pancreatic Cancer
2015-07-01 08:52:42| drugdiscoveryonline Home Page
PharmaEngine, Inc. (TWO: 4162) announced that (1) its license partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), has received the notification from the US Food and Drug Administration (FDA) for the acceptance and the grant of the priority review designation for their New Drug Application (NDA); and (2) its sublicense partner, Baxalta Incorporated, a wholly owned subsidiary of Baxter International Inc. (NYSE: BAX) has received the acceptance of Market Authorization Application (MAA) from the European Medicines Agency (EMA), of MM-398 (irinotecan liposome injection, also known as "nal-IRI,") in the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy
Tags: review
market
application
drug
Elsevier Solutions Address The Challenges Of Lead Optimization In Early Drug Discovery
2015-07-01 08:42:42| drugdiscoveryonline Home Page
Improved content discoverability via Reaxys® Medicinal Chemistry combined with data integration capabilities allow chemists to identify and optimize promising lead candidates
Tags: address
early
lead
solutions
CytRx Unveils Novel LADR (Linker Activated Drug Release) Technology Platform
2015-07-01 08:34:27| drugdiscoveryonline Home Page
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today unveiled its proprietary LADR™ (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage the Company's expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies
Tags: technology
release
drug
platform
ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial
2015-07-01 08:22:45| drugdiscoveryonline Home Page
ABL, Inc. (ABL), a contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the successful aseptic formulation and fill of an Ebola vaccine candidate for Emergent BioSolutions Inc. (EMERGENT)
Tags: product
trial
drug
successfully
Sites : [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] next »